Literature DB >> 7492222

Evidence for a causal relationship between the structure, size, and load of calcium pyrophosphate dihydrate crystals, and attacks of pseudogout.

A Swan1, B Heywood, B Chapman, H Seward, P Dieppe.   

Abstract

OBJECTIVE: To investigate any relationship between the nature, size, and numbers of synovial fluid (SF) calcium pyrophosphate dihydrate (CPPD) crystals, and attacks of pseudogout.
METHODS: Knee SF was aspirated from nine selected patients, first during an attack of pseudogout (acute sample) and again later when the attack had subsided (interval sample). CPPD crystals were extracted, weighed, examined by high resolution transmission electron microscopy (HRTEM), and characterised by size and crystal habit (monoclinic or triclinic). Structural analysis was carried out by x ray powder diffraction (XRD) and the proportions of monoclinic to triclinic CPPD were estimated from densitometric measurements of selected key reflections.
RESULTS: The mean crystal size, by HRTEM, indicated that the crystals in the acute sample were larger than those in the interval sample. The ratio of monoclinic to triclinic CPPD, whether estimated from their morphological appearance by HRTEM, or from XRD, was greater in the acute than in the interval sample in all nine patients. The total amount of extracted mineral varied, but in every patient the concentration of CPPD per ml of fluid, and the total mineral per joint, were greater in the acute sample than in the interval sample.
CONCLUSION: In this highly selected group of patients, the large numbers of CPPD crystals associated with attacks of pseudogout included a greater proportion of monoclinic crystals, and larger crystals, than those present when inflammation had subsided. A special, phlogistic population of crystals may exist, originating in different joint tissues, or cleared in a different manner, than the more common populations of smaller crystals with a greater proportion of triclinic CPPD, seen in chronic disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492222      PMCID: PMC1010018          DOI: 10.1136/ard.54.10.825

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes.

Authors:  P A Guerne; R Terkeltaub; B Zuraw; M Lotz
Journal:  Arthritis Rheum       Date:  1989-11

2.  Inflammatory reactions induced by various calcium pyrophosphate crystals.

Authors:  M Roch-Arveiller; R Legros; B Chanaud; O Muntaner; S Strzalko; A Thuret; D A Willoughby; J P Giroud
Journal:  Biomed Pharmacother       Date:  1990       Impact factor: 6.529

3.  The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.

Authors:  D T Felson; J J Anderson; A Naimark; W Kannel; R F Meenan
Journal:  J Rheumatol       Date:  1989-09       Impact factor: 4.666

4.  Synovial fluid crystals in osteoarthritis.

Authors:  P A Gibilisco; H R Schumacher; J L Hollander; K A Soper
Journal:  Arthritis Rheum       Date:  1985-05

Review 5.  The inflammatory reaction to crystals.

Authors:  R A Terkeltaub; M H Ginsberg
Journal:  Rheum Dis Clin North Am       Date:  1988-08       Impact factor: 2.670

6.  Identification of hydroxyapatite crystals in synovial fluid.

Authors:  P B Halverson; D J McCarty
Journal:  Arthritis Rheum       Date:  1979-04

7.  Studies on the interaction of rheumatoid factor with monosodium urate crystals and case report of coexistent tophaceous gout and rheumatoid arthritis.

Authors:  T P Gordon; M J Ahern; C Reid; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

8.  Formation of calcium pyrophosphate crystals in vitro: implications for calcium pyrophosphate crystal deposition disease (pseudogout).

Authors:  P R Hearn; R G Russell
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

9.  Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.

Authors:  R Terkeltaub; L K Curtiss; A J Tenner; M H Ginsberg
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Survival of calcium pyrophosphate crystals in stored synovial fluids.

Authors:  N W McGill; A Swan; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

View more
  8 in total

1.  Synthesis of triclinic calcium pyrophosphate crystals.

Authors:  P J Groves; R M Wilson; P A Dieppe; R P Shellis
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

2.  The cytospin technique improves the detection of calcium pyrophosphate crystals in synovial fluid samples with a low leukocyte count.

Authors:  Christoph Robier; Franz Quehenberger; Manfred Neubauer; Mariana Stettin; Franz Rainer
Journal:  Rheumatol Int       Date:  2013-02-07       Impact factor: 2.631

Review 3.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

Review 4.  Counterpoint: Hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Kenneth P H Pritzker
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 5.  Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.

Authors:  Abhishek Abhishek; Tuhina Neogi; Hyon Choi; Michael Doherty; Ann K Rosenthal; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2018-06-14       Impact factor: 10.995

6.  Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilage.

Authors:  Christelle Nguyen; Dominique Bazin; Michel Daudon; Aurore Chatron-Colliet; Didier Hannouche; Arnaud Bianchi; Dominique Côme; Alexander So; Nathalie Busso; Nathalie Busso; Frédéric Lioté; Hang-Korng Ea
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

7.  Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.

Authors:  Francesca Oliviero; Paolo Sfriso; Anna Scanu; Ugo Fiocco; Paolo Spinella; Leonardo Punzi
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

8.  Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways.

Authors:  Laure Campillo-Gimenez; Félix Renaudin; Maud Jalabert; Pierre Gras; Marjolaine Gosset; Christian Rey; Stéphanie Sarda; Corinne Collet; Martine Cohen-Solal; Christèle Combes; Frédéric Lioté; Hang-Korng Ea
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.